Cytokinetics (CYTK) Misses Q3 EPS by 35c
Tweet
Share
E-mail
Get Alerts CYTK Hot Sheet
Price: $75.87 +2.35%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q3 EPS of ($1.52), $0.35 worse than the analyst estimate of ($1.17). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $3.16 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Four Tree Island Advisory calls DoubleDown $11.25 offer too low
- Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
